Seeking men and women with treatment resistant depression for a study of an investigational nasal spray.
Participants in this study will be randomly assigned to receive either the investigational drug or a placebo (looks like the drug, but contains no medicine) for 4 weeks. After that period, participants may be eligible to receive the investigational drug for up to an additional 3 months.
What we're hoping for
We are studying whether the investigational drug delivered as a nasal spray is safe and more effective for treatment resistant depression than a placebo (looks like the drug but contains no medicine).
ClinicalTrials.gov Identifier: NCT04599855